The results of a recent study showed that ECI2 is overexpressed in prostate carcinoma on both mRNA and protein levels (detected by immunohistochemistry), and that the increased gene expression of ECI2 predicts statistically significant poor outcome (survival), as analyzed on 144 patient samples32. This evidence concerns the gene ECI2 and prostate carcinoma.